BR0001011B1 - processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina. - Google Patents

processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina.

Info

Publication number
BR0001011B1
BR0001011B1 BRPI0001011-1A BR0001011A BR0001011B1 BR 0001011 B1 BR0001011 B1 BR 0001011B1 BR 0001011 A BR0001011 A BR 0001011A BR 0001011 B1 BR0001011 B1 BR 0001011B1
Authority
BR
Brazil
Prior art keywords
ibdv mutant
infectious ibdv
vaccine
preparation
genetically engineered
Prior art date
Application number
BRPI0001011-1A
Other languages
English (en)
Other versions
BR0001011A (pt
Inventor
Adriaan Antonius Wilhelmus Maria Loon
Egbert Mundt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR0001011A publication Critical patent/BR0001011A/pt
Publication of BR0001011B1 publication Critical patent/BR0001011B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10051—Methods of production or purification of viral material
BRPI0001011-1A 1999-03-05 2000-03-03 processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina. BR0001011B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99200647 1999-03-05

Publications (2)

Publication Number Publication Date
BR0001011A BR0001011A (pt) 2001-07-03
BR0001011B1 true BR0001011B1 (pt) 2011-05-17

Family

ID=8239949

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0001011-1A BR0001011B1 (pt) 1999-03-05 2000-03-03 processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina.

Country Status (14)

Country Link
US (2) US6492148B1 (pt)
EP (1) EP1035203B1 (pt)
JP (2) JP4675447B2 (pt)
KR (1) KR100709077B1 (pt)
AT (1) ATE266097T1 (pt)
BR (1) BR0001011B1 (pt)
CA (1) CA2298956C (pt)
DE (1) DE60010358T2 (pt)
DK (1) DK1035203T3 (pt)
ES (1) ES2220333T3 (pt)
HU (1) HU226254B1 (pt)
PL (1) PL198981B1 (pt)
PT (1) PT1035203E (pt)
ZA (1) ZA200001069B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
EP1421222A4 (en) * 2001-03-09 2004-07-07 Univ California CELL CULTURE SYSTEM FOR SYNTHESIS OF HEPATITIS C INFECTIOUS VIRUS
US20050014201A1 (en) * 2001-10-25 2005-01-20 Mordechai Deuthsch Interactive transparent individual cells biochip processor
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US8597597B2 (en) 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
EP1654347B1 (en) * 2003-06-26 2014-06-04 Seng Enterprises Limited Improved materials for constructing cell-chips, cell-chip covers, cell-chip coats, processed cell-chips and uses thereof
US7982751B2 (en) * 2003-07-11 2011-07-19 The University Of North Carolina Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
US7544805B2 (en) * 2004-02-03 2009-06-09 Chemagis Ltd. Stable amorphous forms of montelukast sodium
EP1763665A1 (en) * 2004-07-07 2007-03-21 Seng Enterprises Limited Method and device for identifying an image of a well in an image of a well-bearing component
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1781404A2 (en) * 2004-08-25 2007-05-09 Seng Enterprises Limited Method and device for isolating cells
US8038964B2 (en) 2005-01-25 2011-10-18 Seng Enterprises Ltd. Device for studying individual cells
DE102005034043B4 (de) * 2005-07-18 2019-12-12 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Gemisch, enthaltend L-Carnitin und Trehalulose, sowie Produkt enthaltend das Gemisch
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
US8288120B2 (en) 2005-11-03 2012-10-16 Seng Enterprises Ltd. Method for studying floating, living cells
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
EP2237887A2 (en) 2007-12-26 2010-10-13 Seng Enterprises Ltd. Device for the study of living cells
EP2407534A1 (en) 2010-07-14 2012-01-18 Neo Virnatech, S.L. Methods and reagents for obtaining transcriptionally active virus-like particles and recombinant virions
CN102258777B (zh) * 2011-06-30 2012-09-26 河南农业大学禽病研究所 用鸡胚源细胞系繁殖传染性法氏囊病毒制备灭活疫苗和联苗的方法
CN111235117B (zh) * 2020-02-13 2021-08-27 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一株自然适应体外细胞培养的鸡传染性法氏囊病病毒经典株及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts

Also Published As

Publication number Publication date
PL338773A1 (en) 2000-09-11
ZA200001069B (en) 2000-10-20
CA2298956C (en) 2009-12-01
KR100709077B1 (ko) 2007-04-19
PL198981B1 (pl) 2008-08-29
DK1035203T3 (da) 2004-08-30
EP1035203B1 (en) 2004-05-06
JP2000312593A (ja) 2000-11-14
HU226254B1 (en) 2008-07-28
HUP0000992A2 (hu) 2000-11-28
BR0001011A (pt) 2001-07-03
JP4675447B2 (ja) 2011-04-20
DE60010358T2 (de) 2004-09-23
JP2011036255A (ja) 2011-02-24
HUP0000992A3 (en) 2005-06-28
PT1035203E (pt) 2004-08-31
US6569422B1 (en) 2003-05-27
HU0000992D0 (en) 2000-05-28
ATE266097T1 (de) 2004-05-15
KR20010069175A (ko) 2001-07-23
ES2220333T3 (es) 2004-12-16
CA2298956A1 (en) 2000-09-05
US6492148B1 (en) 2002-12-10
DE60010358D1 (de) 2004-06-09
EP1035203A1 (en) 2000-09-13

Similar Documents

Publication Publication Date Title
BR0001011B1 (pt) processo para a preparação de um mutante ibdv infeccioso, mutante ibdv infeccioso engenheirado geneticamente, e, vacina.
DE69833652D1 (de) System zum exprimieren einer hyperthermostabilen protease
EP1394259A3 (en) Recombinant infectious non-segmented negative strand RNA virus
DE69737886D1 (de) Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
RU99114325A (ru) Днк, кодирующая мутантную изопропилмалат синтазу, микроорганизм-продуцент l-лейцина и способ получения l-лейцина
HK1083635A1 (en) Animal protein free media for cultivation of cells
DE60144205D1 (de) Verfahren zur Herstellung von L-Lysin unter Verwendung von Escherichia coli
AU3891897A (en) A method for generating birnavirus from synthetic rna transcripts
HU896613D0 (en) Process for the preparation of tgf-betal/beta2 chimer
ATE187496T1 (de) Equine herpesviren (ehv), die fremd-dna enthalten, verfahren zu ihrer herstellung und ihre verwendung in impfstoffen
CA2329510A1 (en) Promoter sequence which is expressed in anthers and in pollen
WO2004091475A3 (en) Gaucher disease drugs and methods of identifying same
DK0677584T3 (da) Stabile mutanter af D-N-alpha-carbamylase
AU2002212555A1 (en) Yeast derived vaccine against ipnv
MXPA01005808A (es) Cepa de virus de enfermedad bursal infecciosa para administracion en huevo.
ATE25708T1 (de) Biologisch aktive konjugate, ihre herstellung und ihre anwendung.
Palukaitis et al. Variation in the hypervariable region of cucumber mosaic virus satellite RNAs is affected by the helper virusand the initial sequence context
EP1074624A4 (en) GENE 62 OF THE ATTENUATED VARICELLA VIRUS STRAIN OKA AND METHOD FOR IDENTIFYING THE VIRUS STRAIN ATTENUATED VARICELLA VACCINE USING THE SAME
ATE399209T1 (de) Verfahren zur herstellung von coenzym q 10
EP1161953A3 (en) IBDV strain for in OVO administration
WO2000037649A3 (en) Dna vaccine against infectious bursal disease virus
TH58474B (th) การสร้างมิวแทนต์ของไวรัสก่อโรคในเบอร์ซา (infectious bursal diseases virus, IBDV) ให้เจริญได้ในเซลล์เพาะเลี้ยงโดยวิธีเชิงพันธุวิศวกรรม
DE69934329D1 (de) Verfahren zur genetischen veränderung einer viralen wildtyp-sequenz
DE60036198D1 (de) Transgener mollusk und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/05/2011, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 18A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)